Candida albicans

1. Fungal infectionsJohn E Edwards1 and Priya Uppuluri2UCLA David Geffen School of Medicine, USA. 1E-mail: jedwards@labiomed.org , 2E-mail: puppuluri@labiomed.org2. Fungal infections- The South-Asian perspectiveArunaloke ChakrabartiDivision of Mycology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. E-mail: arunaloke@gmail.com3. Regulatory pathways during C. albicans infectionsAaron P. MitchellMellon Institute, Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, USA. E-mail: apm1@andrew.cmu.edu4. Virulence mechanisms and regulationChristophe D'EnfertFungal Biology and Pathogenicity Unit - INRA USC2019, Department of Mycology, Institut Pasteur, Paris, France. E-mail: christophe.denfert@pasteur.fr 5. Signalling mechanisms in pathogenesis and virulence of C. albicansNeeraj ChauhanPublic Health Research Institute Center, New Jersey Medical School - Rutgers, The State University of New Jersey, Newark New Jersey, USA. E-mail: chauhan1@njms.rutgers.edu 6. Biofilm development by C. albicansDavid AndesDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI, USA. E-mail: dra@medicine.wisc.edu7. Biofilm development and resistance mechanisms by C. albicansPatrick Van Dijck1 and Mary-Ann Jabra Rizk21 VIB Department of Molecular Microbiology, KU Leuven, Kasteelpark, Arenberg, Leuven, Belgium. 2 University of Maryland School of Dentistry, Maryland, USA. 1E-mail: Patrick.VanDijck@mmbio.vib-kuleuven.be, 2E-mail: MRizk@umaryland.edu8. Biofilm of C. albicans : development and regulationAshraf S. Ibrahim1 and Priya Uppuluri2UCLA David Geffen School of Medicine. USA, 1E-mail: ibrahim@labiomed.org, 2E-mail: puppuluri@labiomed.org9. Host immune responses during infectionsGordon BrownThe Institute of Medical Sciences, University of Aberdeen, Scotland. E-mail: gordon.brown@abdn.ac.uk10. Mechanism of drug resistance Dominique SanglardInstitute of Microbiology, University Hospital Lausanne and University Hospital Center, Lausanne, Switzerland. E-mail: Dominique.Sanglard@chuv.ch11. Structure- function analyses of Multi-drug transportersRichard D. Cannon Department of Oral Sciences, University of Otago, Dunedin, New Zealand. E-mail: richard.cannon@otago.ac.nz12. All about MFS multi-drug transporter of Candida albicansRajendra Prasad1, Peer Abdul Haseeb Shah2 and Archana Redhu21Amity Institute of Integrative Sciences and Health and Amity Institute of Biotechnology, Amity University, Haryana, India. 2Membrane biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India. 1E-mail: rp47jnu@gmail.com, rprasad@ggn.amity.edu13. Inhibitors/Modulators of MDR transporters Attilio Di PietroInstitute for the Biology and Chemistry of Protein, Lyon, France. E-mail : a.dipietro@ibcp.fr14. Inhibitors/Modulators of MDR proteins/transportersBrian MonkDepartment of Oral Sciences, University of Otago, Dunedin, New Zealand. E-mail: brian.monk@otago.ac.nz15. Anti-fungals David PerlinPublic Health Research Institute Center, New Jersey Medical School - Rutgers, The State University of New Jersey, New Jersey, USA. E-mail: perlinds@umdnj.edu16. Anti-microbial peptidesJoachim Ernst and Marc SwidergallInstitut fur Mikrobiologie, Molekulare Mykologie, Heinrich-Heine-Universitat, D-40225 Dusseldorf, Germany. E-mail: Joachim.Ernst@uni-duesseldorf.de17. Anti-candidial agentsSlawomir MilewskiDepartment of Pharmaceutical Technology and Biochemistry, Technical University of Gdansk, Poland. E-mail: slamilew@pg.gda.pl18. MDR1 and its regulationJoachim MorschhauserInstitut fur Molekulare Infektionsbiologie, Universitat Wurzburg, Wurzburg, Germany.E-mail: joachim.morschhaeuser@uni-wuerzburg.de19. Genomics and Anti-fungal resistance Kaustuv SanyalMolecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore, India. E-mail: sanyal@jncasr.ac.in20. Genomics and Anti-fungal resistance Judith BermanDept. of Molecular Microbiology & Biotechnology, George Wise Faculty of Life Sciences, Tel Aviv University, Israel. E-mail: Jberman@post.tau.ac.il21. Lipids and Multi-drug resistance in Candida albicansRajendra Prasad1and Ashutosh Singh21Amity Institute of Integrative Sciences and Health and Amity Institute of Biotechnology, Amity University, Haryana, India. 2Department of Molecular Genetics and Microbiology, Stony Brook University, New York, USA. 1E-mail: rp47jnu@gmail.com, rprasad@ggn.amity.edu, 2E-mail: ashutosh.singh29@gmail.com22. Cell wall of Candida albicans and its role in virulence Neil A. R. GowThe Institute of Medical Sciences, University of Aberdeen, Scotland. E-mail: n.gow@abdn.ac.uk23. Hyphal morphogenesis of C. albicansMichael LorenzDepartment of Microbiology and Molecular Genetics, University of Texas Health Science Center, USA. E-mail: Michael.Lorenz@uth.tmc.edu24. Innate immune defences against fungal infectionsMichael YeamanUCLA David Geffen School of Medicine, USA, E-mail: MRYeaman@ucla.edu "/div>